Life Cycle Investment Partners Ltd
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 2072459
LONDON, X0
Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,041,132
New position
Shares Held
209,068
first reported quarter
Ownership
0.148%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#69
of 497 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Life Cycle Investment Partners Ltd holds $427,063,558 across 10 Biotechnology names. ARWR ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
514,179 | $255,408,134 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,424 | $49,797,586 | |
| 3 | ARGX |
Argenx SE
|
22,490 | $20,865,547 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
73,048 | $20,816,488 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
219,896 | $17,435,553 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
209,068 | $17,041,132 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
35,124 | $13,054,537 | |
| 8 | ADMA |
Adma Biologics, Inc.
|
1,522,981 | $12,747,350 |
All Filings in ARWR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,041,132 | 209,068 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||